Questions about getting a COVID-19 vaccine? See the latest on our blog

Drug Changes


Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.

To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:


Denavir Cream 1 % External


Post Date:
2/1/2023
Effective Date:
2/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Penciclovir Cream 1 % External Tier 2 ST Topical Anti-infectives
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tazorac Gel 0.05 % External


Post Date:
2/1/2023
Effective Date:
2/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tazarotene Gel 0.05 % External Tier 4 Acne and Rosacea Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tazorac Gel 0.1 % External


Post Date:
2/1/2023
Effective Date:
2/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tazarotene Gel 0.1 % External Tier 4 Acne and Rosacea Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Esbriet Capsule 267 MG Oral


Post Date:
3/27/2023
Effective Date:
4/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pirfenidone Capsule 267 MG Oral Tier 5 PA, QL Pulmonary Fibrosis Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Hetlioz Capsule 20 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tasimelteon Capsule 20 MG Oral Tier 5 PA, QL Sleep Promoting Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Latuda Tablet 120 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lurasidone HCl Tablet 120 MG Oral Tier 5 2nd Generation/Atypical
* Please reference your Evidence of Coverage for applicable cost-sharing.

Latuda Tablet 20 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lurasidone HCl Tablet 20 MG Oral Tier 5 QL 2nd Generation/Atypical
* Please reference your Evidence of Coverage for applicable cost-sharing.

Latuda Tablet 40 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lurasidone HCl Tablet 40 MG Oral Tier 5 QL 2nd Generation/Atypical
* Please reference your Evidence of Coverage for applicable cost-sharing.

Latuda Tablet 60 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lurasidone HCl Tablet 60 MG Oral Tier 5 QL 2nd Generation/Atypical
* Please reference your Evidence of Coverage for applicable cost-sharing.

Latuda Tablet 80 MG Oral


Post Date:
4/25/2023
Effective Date:
5/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lurasidone HCl Tablet 80 MG Oral Tier 5 2nd Generation/Atypical
* Please reference your Evidence of Coverage for applicable cost-sharing.

Cardizem LA Tablet Extended Release 24 Hour 120 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
dilTIAZem HCl ER Tablet Extended Release 24 Hour 120 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Kyzatrex Capsule 100 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Testosterone Cypionate Solution 100 MG/ML Intramuscular Tier 2 Androgens
Testosterone Cypionate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Enanthate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Gel 10 MG/ACT (2%) Transdermal Tier 2 QL Androgens
Testosterone Gel 12.5 MG/ACT (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 25 MG/2.5GM (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 50 MG/5GM (1%) Transdermal Tier 2 QL Androgens
* Please reference your Evidence of Coverage for applicable cost-sharing.

Kyzatrex Capsule 150 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Testosterone Cypionate Solution 100 MG/ML Intramuscular Tier 2 Androgens
Testosterone Cypionate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Enanthate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Gel 10 MG/ACT (2%) Transdermal Tier 2 QL Androgens
Testosterone Gel 12.5 MG/ACT (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 25 MG/2.5GM (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 50 MG/5GM (1%) Transdermal Tier 2 QL Androgens
* Please reference your Evidence of Coverage for applicable cost-sharing.

Kyzatrex Capsule 200 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Testosterone Gel 12.5 MG/ACT (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 25 MG/2.5GM (1%) Transdermal Tier 2 QL Androgens
Testosterone Gel 50 MG/5GM (1%) Transdermal Tier 2 QL Androgens
Testosterone Cypionate Solution 100 MG/ML Intramuscular Tier 2 Androgens
Testosterone Cypionate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Enanthate Solution 200 MG/ML Intramuscular Tier 2 Androgens
Testosterone Gel 10 MG/ACT (2%) Transdermal Tier 2 QL Androgens
* Please reference your Evidence of Coverage for applicable cost-sharing.

Matzim LA Tablet Extended Release 24 Hour 180 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Matzim LA Tablet Extended Release 24 Hour 180 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Matzim LA Tablet Extended Release 24 Hour 240 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Matzim LA Tablet Extended Release 24 Hour 240 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Matzim LA Tablet Extended Release 24 Hour 300 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Matzim LA Tablet Extended Release 24 Hour 300 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Matzim LA Tablet Extended Release 24 Hour 360 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Matzim LA Tablet Extended Release 24 Hour 360 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Matzim LA Tablet Extended Release 24 Hour 420 MG Oral


Post Date:
5/18/2023
Effective Date:
6/1/2023
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Matzim LA Tablet Extended Release 24 Hour 420 MG Oral Tier 2 Calcium Channel Blocking Agents, Nondihydropyridines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Naftin Gel 2 % External


Post Date:
6/20/2023
Effective Date:
7/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Naftifine HCl Gel 2 % External Tier 4 Antifungals
* Please reference your Evidence of Coverage for applicable cost-sharing.

Noxafil Suspension 40 MG/ML Oral


Post Date:
6/20/2023
Effective Date:
7/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Posaconazole Suspension 40 MG/ML Oral Tier 5 PA Antifungals
* Please reference your Evidence of Coverage for applicable cost-sharing.

Celontin Capsule 300 MG Oral


Post Date:
7/26/2023
Effective Date:
8/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Methsuximide Capsule 300 MG Oral Tier 4 Calcium Channel Modifying Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Iressa Tablet 250 MG Oral


Post Date:
7/26/2023
Effective Date:
8/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Gefitinib Tablet 250 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Orfadin Capsule 20 MG Oral


Post Date:
7/26/2023
Effective Date:
8/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Nitisinone Capsule 20 MG Oral Tier 5 PA Genetic or Enzyme or Protein Disorder: Replacement, Modifiers, Treatment
* Please reference your Evidence of Coverage for applicable cost-sharing.

Prezista Tablet 600 MG Oral


Post Date:
8/25/2023
Effective Date:
9/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Darunavir Tablet 600 MG Oral Tier 5 Anti-HIV Agents, Protease Inhibitors (PI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Prezista Tablet 800 MG Oral


Post Date:
8/25/2023
Effective Date:
9/1/2023
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Darunavir Tablet 800 MG Oral Tier 5 Anti-HIV Agents, Protease Inhibitors (PI)
* Please reference your Evidence of Coverage for applicable cost-sharing.